×
About 10,825 results

ALLMedicine™ Ankylosing Spondylitis Center

Research & Reviews  2,904 results

Impact of the number of comorbidities on the outcome measures and on the retention rate...
https://doi.org/10.1016/j.semarthrit.2021.12.007
Seminars in Arthritis and Rheumatism; Puche-Larrubia MÁ, Ladehesa-Pineda L et. al.

Jan 15th, 2022 - To evaluate the impact of the number of comorbidities on the outcome measures after two years of follow-up in patients with Ankylosing Spondylitis (AS) and to determine whether the number of comorbidities influences the retention rate of the first...

Association between Klebsiella pneumoniae and ankylosing spondylitis: A systematic revi...
https://doi.org/10.1111/1756-185X.14283
International Journal of Rheumatic Diseases; Long F, Wang T et. al.

Jan 13th, 2022 - The aim of this study is to evaluate the association between Klebsiella pneumoniae infection and ankylosing spondylitis (AS). Five electronic databases, PubMed, Embase, Medline, Web of Science, and Scopes, were searched until September 29, 2021. C...

Both ASDAS and ADC are associated with spinal mobility in active axial spondyloarthriti...
https://doi.org/10.1111/1756-185X.14278
International Journal of Rheumatic Diseases; Chung HY, Chan SCW et. al.

Jan 13th, 2022 - Using diffusion-weighted imaging (DWI)-derived apparent diffusion coefficient (ADC), we aimed to determine the relationship between intensity of spinal inflammation and mobility in patients with axial spondyloarthritis (SpA) in early and later sta...

Genetic Determinants of Ankylosing Spondylitis Severity - Longitudinal Study
https://clinicaltrials.gov/ct2/show/NCT00056719

Jan 13th, 2022 - The susceptibility to ankylosing spondylitis (AS) is largely genetically determined. Recent studies suggest that the severity of AS is also influenced by genetic factors. The goal of this study is to identify genes that influence the severity of A...

P076 The Role of Dual Biologic Therapy in Inflammatory Bowel Disease.
https://doi.org/10.14309/01.ajg.0000798904.09135.49
The American Journal of Gastroenterology; Stone M, Morrison M et. al.

Jan 11th, 2022 - As the prevalence of complex inflammatory bowel disease and extraintestinal manifestations continue to rise, more patients are requiring complex treatment regimens. In some cases, patients may require more than one biologic agent to target differe...

see more →

Guidelines  11 results

2019 Update of the American College of Rheumatology/Spondylitis Association of America/...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764882
Arthritis & Rheumatology (Hoboken, N.J.); Ward MM, Deodhar A et. al.

Aug 23rd, 2019 - To update evidence-based recommendations for the treatment of patients with ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA). We conducted updated systematic literature reviews for 20 clinical questions on pharmacologi...

Responsible, Safe, and Effective Use of Antithrombotics and Anticoagulants in Patients ...
https://www.ncbi.nlm.nih.gov/pubmed/30717501
Pain Physician; Kaye AD, Manchikanti L et. al.

Feb 6th, 2019 - Interventional pain management involves diagnosis and treatment of chronic pain. This specialty utilizes minimally invasive procedures to target therapeutics to the central nervous system and the spinal column. A subset of patients encountered in ...

The effectiveness, safety, and economic evaluation of Korean medicine for unexplained i...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779787
Medicine

Mar 6th, 2018 - Therapeutic targets have been defined for axial and peripheral spondyloarthritis (SpA) in 2012, but the evidence for these recommendations was only of indirect nature. These recommendations were re-evaluated in light of new insights. Based on the ...

2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis.
https://doi.org/10.1136/annrheumdis-2016-210770
Annals of the Rheumatic Diseases; van der Heijde D, Ramiro S et. al.

Jan 15th, 2017 - To update and integrate the recommendations for ankylosing spondylitis and the recommendations for the use of tumour necrosis factor inhibitors (TNFi) in axial spondyloarthritis (axSpA) into one set applicable to the full spectrum of patients with...

EULAR recommendations for cardiovascular disease risk management in patients with rheum...
https://doi.org/10.1136/annrheumdis-2016-209775
Annals of the Rheumatic Diseases; Agca R, Heslinga SC et. al.

Oct 5th, 2016 - Patients with rheumatoid arthritis (RA) and other inflammatory joint disorders (IJD) have increased cardiovascular disease (CVD) risk compared with the general population. In 2009, the European League Against Rheumatism (EULAR) taskforce recommend...

see more →

Drugs  767 results see all →

Clinicaltrials.gov  106 results

Genetic Determinants of Ankylosing Spondylitis Severity - Longitudinal Study
https://clinicaltrials.gov/ct2/show/NCT00056719

Jan 13th, 2022 - The susceptibility to ankylosing spondylitis (AS) is largely genetically determined. Recent studies suggest that the severity of AS is also influenced by genetic factors. The goal of this study is to identify genes that influence the severity of A...

Progression of Spinal Fusion in Ankylosing Spondylitis
https://clinicaltrials.gov/ct2/show/NCT00085995

Jan 11th, 2022 - Spinal fusion is the clinical, radiological, and pathological hallmark of ankylosing spondylitis (AS). However, spinal fusion occurs slowly in AS. Serial radiographs rarely show changes over 2 years, and often 5 or more years are needed to demonst...

A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic ...
https://clinicaltrials.gov/ct2/show/NCT04527380

Jan 5th, 2022 - The reason for this study is to see if the study drug ixekizumab is safe and effective in children with juvenile idiopathic arthritis (JIA) categories of enthesitis-related arthritis (ERA) (including juvenile onset ankylosing spondylitis [JoAS]) a...

The Effects of Tele-Yoga in Ankylosing Spondylitis Patients
https://clinicaltrials.gov/ct2/show/NCT04803383

Jan 4th, 2022 - Yoga is an ancient discipline that emerged in India thousands of years ago, designed to bring balance and health to the physical, mental, emotional and spiritual dimensions of the individual.Due to its therapeutic effects, yoga can be considered a...

A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritis
https://clinicaltrials.gov/ct2/show/NCT03733925

Jan 3rd, 2022 - This post-marketing study will evaluate safety and efficacy profile of golimumab (a fully human anti-Tumour Necrosis Factor alpha [TNF-alpha] monoclonal antibodies [mAb], administered subcutaneously) in a real-world in Indian participants with act...

see more →

News  531 results

Tofacitinib Approved for New Ankylosing Spondylitis Indication
https://www.medscape.com/viewarticle/964978

Dec 16th, 2021 - The US Food and Drug Administration (FDA) approved a supplemental new drug application for tofacitinib (Xeljanz, Xeljanz XR) that adds active ankylosing spondylitis in adults to its list of indications, according to a December 14 announcement from...

Year in Review: Crohn's Disease
https://www.medpagetoday.com/gastroenterology/inflammatoryboweldisease/96216

Dec 15th, 2021 - Cyltezo, the first interchangeable biosimilar for adalimumab (Humira), was approved for Crohn's disease, while research continued on additional therapeutic options, including a study that compared two different biologics head-to-head. Studies also...

Upadacitinib (Rinvoq) Gains Psoriatic Arthritis as Second FDA-Approved Indication
https://www.medscape.com/viewarticle/964858

Dec 15th, 2021 - The US Food and Drug Administration has approved a 15-mg extended release tablet of upadacitinib (Rinvoq) for adults with psoriatic arthritis who had an inadequate response or intolerance to one or more anti-tumor necrosis factor drugs, manufactur...

Peripheral manifestations make mark on spondyloarthritis trajectory
https://www.mdedge.com/rheumatology/article/249542/spondyloarthropathies/peripheral-manifestations-make-mark
Heidi Splete

Dec 7th, 2021 - Peripheral manifestations contribute significantly to disease activity in adults with spondyloarthritis (SpA), point toward a generally worse prognosis, and play a big role in defining the phenotypic clustering of the heterogenous disease, accordi.

Peripheral Manifestations Influence Spondyloarthritis Trajectory
https://www.medscape.com/viewarticle/964334

Dec 7th, 2021 - Peripheral manifestations contribute significantly to disease activity in adults with spondyloarthritis (SpA), point toward a generally worse prognosis, and play a big role in defining the phenotypic clustering of the heterogenous disease, accordi...

see more →

Patient Education  11 results see all →